[1]
|
Arnold, M., Abnet, C.C., Neale, R.E., et al. (2020) Global Burden of 5 Major Types of Gastrointestinal Cancer. Gas-troenterology, 159, 335-349. https://doi.org/10.1053/j.gastro.2020.02.068
|
[2]
|
Feng, R.-M., Zong, Y.-N., Cao, S.-M. and Xu, R.H. (2019) Current Cancer Situation in China: Good or Bad News from the 2018 Global Cancer Statis-tics? Cancer Communications, 39, 1-22.
https://doi.org/10.1186/s40880-019-0368-6
|
[3]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[4]
|
Madhavan, S. and Nagarajan, S. (2020) GRP78 and Next Generation Cancer Hallmarks: An Underexplored Molecular Target in Cancer Chemoprevention Research. Biochimie, 175, 69-76. https://doi.org/10.1016/j.biochi.2020.05.005
|
[5]
|
Hendershot, L.M., Valentine, V.A., Lee, A.S., Morris, S.W. and Shapiro, D.N. (1994) Localization of the Gene Encoding Human BiP/GRP78, the Endoplasmic Reticulum Cognate of the HSP70 Family, to Chromosome 9q34. Genomics, 20, 281-284. https://doi.org/10.1006/geno.1994.1166
|
[6]
|
Haas, I.G. (1991) BiP—A Heat Shock Protein Involved in Immunoglobulin Chain Assembly. Current Topics in Microbiology and Immunology, 167, 71-82.
|
[7]
|
Hernandez, I. and Cohen, M. (2022) Linking Cell-Surface GRP78 to Cancer: From Basic Research to Clinical Value of GRP78 Antibodies. Cancer Letters, 524, 1-14. https://doi.org/10.1016/j.canlet.2021.10.004
|
[8]
|
Ren, P., Chen, C., Yue, J., Zhang, J. and Yu, Z. (2017) High Expression of Glucose-Regulated Protein 78 (GRP78) Is Associated with Metastasis and Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy, 10, 617-625. https://doi.org/10.2147/OTT.S123494
|
[9]
|
Zheng, H.C., Gong, B.C. and Zhao, S. (2017) The Meta and Bioin-formatics Analysis of GRP78 Expression in Gastric Cancer. Oncotarget, 8, 73017-73028. https://doi.org/10.18632/oncotarget.20318
|
[10]
|
Ahmadi, A., Khansarinejad, B., Hosseinkhani, S., Ghanei, M. and Mowla, S.J. (2017) miR-199a-5p and miR-495 Target GRP78 within UPR Pathway of Lung Cancer. Gene, 620, 15-22. https://doi.org/10.1016/j.gene.2017.03.032
|
[11]
|
Zielinska, H.A., Daly, C.S., Alghamdi, A., et al. (2020) Interaction between GRP78 and IGFBP-3 Affects Tumourigenesis and Prognosis in Breast Cancer Patients. Cancers, 12, Article No. 3821. https://doi.org/10.3390/cancers12123821
|
[12]
|
Jiang, B., Zhang, R., Zhang, J., et al. (2019) GRP78-Targeted Ferritin Nanocaged Ultra-High Dose of Doxorubicin for Hepatocellular Carcinoma Therapy. Theranostics, 9, 2167-2182. https://doi.org/10.7150/thno.30867
|
[13]
|
顾雪, 余美玲, 肖成炜, 等. 葡萄糖调节蛋白78在卵巢癌侵袭转移中的作用[J]. 蚌埠医学院学报, 2019, 44(9): 1148-1152+1157.
|
[14]
|
Liao, Y., Liu, Y., Xia, X., et al. (2020) Targeting GRP78-Dependent AR-V7 Protein Degradation Overcomes Castration-Resistance in Prostate Cancer Therapy. Theranostics, 10, 3366-3381. https://doi.org/10.7150/thno.41849
|
[15]
|
Farshbaf, M., Khosroushahi, A.Y., Mojarad-Jabali, S., et al. (2020) Cell Surface GRP78: An Emerging Imaging Marker and Therapeutic Target for Cancer. Journal of Controlled Release, 328, 932-941.
https://doi.org/10.1016/j.jconrel.2020.10.055
|
[16]
|
Huang, J., Koulaouzidis, A., Marlicz, W., et al. (2021) Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries. Cancers, 13, Article No. 141.
https://doi.org/10.3390/cancers13010141
|
[17]
|
魏鹏飞, 黄辉, 陈明霞, 等. 不同部位食管癌患者放疗联合化疗的干预效果以及3年内发生转移的影响因素分析[J]. 中国医药, 2020, 15(6): 898-902.
|
[18]
|
董孝成, 陈绍森, 赵恩亮. 不同组织学类型食管癌GRP78的表达及其临床病理特征的相关性研究[J]. 中国地方病防治杂志, 2016, 31(9): 1030-1031.
|
[19]
|
彭蓉, 娜吧错, 益西卓呷. 不同病理类型食管癌GRP78、GRP94表达及与预后的关系分析[J]. 解放军医药杂志, 2020, 32(7): 22-26.
|
[20]
|
Zhao, G., Kang, J., Jiao, K., et al. (2015) High Expression of GRP78 Promotes Invasion and Metastases in Patients with Esophageal Squamous Cell Carcinoma. Digestive Diseases and Sciences, 60, 2690-2699.
https://doi.org/10.1007/s10620-015-3689-6
|
[21]
|
丁伟超, 马岩岩, 邱贤秀, 王绍祥, 王莹, 任哲. GRP78在食管癌细胞ECA-109增殖过程中的功能研究[J]. 中国细胞生物学学报, 2013, 35(1): 41-46.
|
[22]
|
Diamantis, A., Samara, A.A., Baloyiannis, I., et al. (2021) Gastrointestinal Stromal Tumor (GIST) and Synchronous Intra-Abdominal Liposarcoma: A Report of Two Rare Cases and Literature Review. International Journal of Surgical Oncology, 2021, Article ID: 2626635. https://doi.org/10.1155/2021/2626635
|
[23]
|
Etemadi, A., Safiri, S., Sepanlou, S.G., et al. (2020) The Global, Regional, and National Burden of Stomach Cancer in 195 Countries, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology, 5, 42-54. https://doi.org/10.1016/S2468-1253(19)30328-0
|
[24]
|
Yang, L., Yang, S., Liu, J., et al. (2014) Expression of GRP78 Predicts Taxane-Based Therapeutic Resistance and Recurrence of Human Gastric Cancer. Experimental and Molecular Pathology, 96, 235-241.
https://doi.org/10.1016/j.yexmp.2014.02.011
|
[25]
|
Kang, J.M., Park, S., Kim, S.J., et al. (2015) KIAA1324 Sup-presses Gastric Cancer Rogression by Inhibiting the Oncoprotein GRP78. Cancer Research, 75, 3087-3097. https://doi.org/10.1158/0008-5472.CAN-14-3751
|
[26]
|
Wang, X., Wu, X., Wang, Q., et al. (2020) NLRP6 Sup-presses Gastric Cancer Growth via GRP78 Ubiquitination. Experimental Cell Research, 395, Article ID: 112177. https://doi.org/10.1016/j.yexcr.2020.112177
|
[27]
|
Zhang, J., Jiang, Y., Jia, Z., et al. (2006) Association of Elevated GRP78 Expression with Increased Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer. Clinical & Experimental Metastasis, 23, 401-410.
https://doi.org/10.1007/s10585-006-9051-9
|
[28]
|
Zhang, X., Zhang, L., Wang, S., Wu, D. and Yang, W. (2015) Decreased Functional Expression of Grp78 and Grp94 Inhibits Proliferation and Attenuates Apoptosis in a Human Gastric Cancer Cell Line in Vitro. Oncology Letters, 9, 1181-1186. https://doi.org/10.3892/ol.2014.2831
|
[29]
|
Fang, S., Hong, H., Li, L., et al. (2017) Plasminogen Kringle 5 Suppresses Gastric Cancer via Regulating HIF-1α and GRP78. Cell Death & Disease, 8, e3144. https://doi.org/10.1038/cddis.2017.528
|
[30]
|
仲杨. 葡萄糖调节蛋白-78在胃癌组织中的表达变化及其意义[J]. 山西医药杂志, 2019, 48(20): 2470-2473.
|
[31]
|
Qin, J., Yang, Q., Ye, H., et al. (2020) Using Serological Proteome Analysis to Identify and Evaluate Anti-GRP78 Autoantibody as Biomarker in the Detection of Gastric Cancer. Journal of Oncology, 2020, Article ID: 9430737.
https://doi.org/10.1155/2020/9430737
|
[32]
|
Rasool, M., Malik, A., Waquar, S., et al. (2021) Assessment of Clinical Variables as Predictive Markers in the Development and Progression of Colorectal Cancer. Bioengineered, 12, 2288-2298.
https://doi.org/10.1080/21655979.2021.1933680
|
[33]
|
Ji, D., Zhan, T., Li, M., et al. (2018) Enhancement of Sen-sitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. Stem Cell Reports, 11, 1506-1522. https://doi.org/10.1016/j.stemcr.2018.10.015
|
[34]
|
Petrik, A.F., Green, B.B., Vollmer, W.M., et al. (2016) The Validation of Electronic Health Records in Accurately Identifying Patients Eligible for Colorectal Cancer Screening in Safety Net Clinics. Family Practice, 33, 639-643.
https://doi.org/10.1093/fampra/cmw065
|
[35]
|
Chen, Z., Wang, C., Dong, H., et al. (2020) Aspirin Has a Better Effect on PIK3CA Mutant Colorectal Cancer Cells by PI3K/Akt/Raptor Pathway. Molecular Medicine, 26, Article No. 14. https://doi.org/10.1186/s10020-020-0139-5
|
[36]
|
Xing, X., Li, Y., Liu, H., Wang, L. and Sun, L. (2011) Glucose Regulated Protein 78 (GRP78) Is Overexpressed in Colorectal Carcinoma and Regulates Colorectal Carcinoma Cell Growth and Apoptosis. Acta Histochemica, 113, 777-782. https://doi.org/10.1016/j.acthis.2010.11.006
|
[37]
|
胡邱宇, 王强, 李喜霞, 吴清明. 葡萄糖调节蛋白78表达水平与大肠癌关系的Meta分析[J]. 华中科技大学学报(医学版), 2018, 47(6): 743-749.
|
[38]
|
Gong, C., Hu, X., Xu, Y., et al. (2020) Berberine Inhibits Proliferation and Migration of Colorectal Cancer Cells by Downregulation of GRP78. Anti-Cancer Drugs, 31, 141-149. https://doi.org/10.1097/CAD.0000000000000835
|
[39]
|
邢智伟, 乔晓娟, 马补换, 等. miR-340通过靶向GRP78促进结直肠癌细胞凋亡并抑制其增殖、迁移和侵袭[J]. 中国生物化学与分子生物学报, 2021, 37(4): 516-523.
|
[40]
|
Li, Z., Zhang, L., Zhao, Y., et al. (2013) Cell-Surface GRP78 Facilitates Colorectal Cancer Cell Migra-tion and Invasion. The International Journal of Biochemistry & Cell Biology, 45, 987-994.
|
[41]
|
Huang, K.C., Chiang, S.F., Yang, P.C., et al. (2021) ATAD3A Stabilizes GRP78 to Suppress ER Stress for Acquired Chemoresistance in Colorectal Cancer. Journal of Cellular Physiology, 236, 6481-6495.
https://doi.org/10.1002/jcp.30323
|
[42]
|
Chern, Y.J., Wong, J.C.T., Cheng, G.S.W., et al. (2019) The Interaction between SPARC and GRP78 Interferes with ER Stress Signaling and Potentiates Apoptosis via PERK/eIF2α and IRE1α/XBP-1 in Colorectal Cancer. Cell Death & Disease, 10, Article No. 504. https://doi.org/10.1038/s41419-019-1687-x
|
[43]
|
Mhaidat, N.M., Alzoubi, K.H., Almomani, N. and Khabour, O. (2015) Expression of Glucose Regulated Protein 78 (GRP78) Determines Colorectal Cancer Response to Chemotherapy. Cancer Biomarkers, 15, 197-203.
https://doi.org/10.3233/CBM-140454
|
[44]
|
Forner, A., Llovet, J.M. and Bruix, J. (2012) Hepatocellular Carcinoma. The Lancet, 379, 1245-1255.
https://doi.org/10.1016/S0140-6736(11)61347-0
|
[45]
|
Craig, A.J., von Felden, J., Garcia-Lezana, T., Sarcognato, S. and Villanueva, A. (2020) Tumour Evolution in Hepatocellular Carcinoma. Nature Reviews Gastroenterology & Hepatology, 17, 139-152.
https://doi.org/10.1038/s41575-019-0229-4
|
[46]
|
赵玮. GRP78及COX-2在肝癌组织中的表达及其相关性研究[D]: [硕士学位论文]. 合肥: 安徽医科大学, 2017.
|
[47]
|
曾经章, 杨勤, 谢汝佳, 等. 肝细胞癌组织中GRP78和p-PERK蛋白的表达及其与临床病理特征的关系[J]. 贵州医科大学学报, 2021, 46(5): 517-523.
|
[48]
|
阳媛. GRP78促进肝癌细胞增殖迁移侵袭的机制研究[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2019.
|
[49]
|
Tai, C.J., Chin-Sheng, H., Kuo, L.J., et al. (2012) Survivin-Mediated Cancer Cell Migration through GRP78 and Epitheli-al-Mesenchymal Transition (EMT) Marker Expression in Mahlavu Cells. Annals of Surgical Oncology, 19, 336-343. https://doi.org/10.1245/s10434-011-1692-5
|
[50]
|
Xia, W., Zhuang, J., Wang, G., et al. (2017) P4HB Promotes HCC Tumorigenesis through Downregulation of GRP78 and Subsequent Upregulation of Epithelial-to-Mesenchymal Transition. Oncotarget, 8, 8512-8521.
https://doi.org/10.18632/oncotarget.14337
|
[51]
|
Xiong, H., Xiao, H., Luo, C., et al. (2019) GRP78 Activates the Wnt/HOXB9 Pathway to Promote Invasion and Metastasis of Hepatocellular Carcinoma by Chaperoning LRP6. Ex-perimental Cell Research, 383, Article ID: 111493.
https://doi.org/10.1016/j.yexcr.2019.07.006
|
[52]
|
Luo, C., Xiong, H., Chen, L., et al. (2018) GRP78 Promotes Hepatocellular Carcinoma Proliferation by Increasing FAT10 Expression through the NF-κB Pathway. Experimental Cell Research, 365, 1-11.
https://doi.org/10.1016/j.yexcr.2018.02.007
|
[53]
|
Aran, G., Sanjurjo, L., Bárcena, C., et al. (2018) CD5L Is Upregulated in Hepatocellular Carcinoma and Promotes Liver Cancer Cell Proliferation and Antiapoptotic Responses by Binding to HSPA5 (GRP78). The FASEB Journal, 32, 3878-3891. https://doi.org/10.1096/fj.201700941RR
|
[54]
|
马海东, 曹洁, 高龙, 付文康, 等. 葡萄糖调节蛋白78对肝癌预后及肿瘤细胞增殖的影响[J]. 中华消化外科杂志, 2021, 20(12): 1294-1305.
|
[55]
|
Zhou, B., Xu, J.W., Cheng, Y.G., et al. (2017) Early Detection of Pancreatic Cancer: Where Are We Now and Where Are We Going? International Journal of Cancer, 141, 231-241. https://doi.org/10.1002/ijc.30670
|
[56]
|
Ilic, M. and Ilic, I. (2016) Epidemiology of Pancreatic Cancer. World Journal of Gastroenterology, 22, 9694-9705.
https://doi.org/10.3748/wjg.v22.i44.9694
|
[57]
|
Lin, Q.-J., Yang, F., Jin, C. and Fu, D.-L. (2015) Current Status and Progress of Pancreatic Cancer in China. World Journal of Gastroenterology, 21, 7988-8003. https://doi.org/10.3748/wjg.v21.i26.7988
|
[58]
|
Ansari, D., Tingstedt, B., Andersson, B., et al. (2016) Pancreatic Cancer: Yesterday, Today and Tomorrow. Future Oncology, 12, 1929-1946. https://doi.org/10.2217/fon-2016-0010
|
[59]
|
Goral, V. (2015) Pancreatic Cancer: Pathogenesis and Diagnosis. Asian Pacific Journal of Cancer Prevention, 16, 5619-5624. https://doi.org/10.7314/APJCP.2015.16.14.5619
|
[60]
|
杜进兵, 李清华. GRP78蛋白在胰腺癌中的表达及对胰腺癌细胞增殖和凋亡的影响研究[J]. 中国医学装备, 2014, 11(8): 47-51.
|
[61]
|
沈珊珊, 蒋廷页, 杨天宇, 等. 胰腺癌中GRP78表达及其对预后的影响[J]. 临床与实验病理学杂志, 2020, 36(12): 1393-1396.
|
[62]
|
Niu, Z., Wang, M., Zhou, L., et al. (2015) Elevated GRP78 Expression Is Associated with Poor Prognosis in Patients with Pancreatic Cancer. Scientific Reports, 5, Article No. 16067. https://doi.org/10.1038/srep16067
|
[63]
|
Shen, J., Ha, D.P., Zhu, G., et al. (2017) GRP78 Haploinsufficiency Sup-presses Acinar-to-Ductal Metaplasia, Signaling, and Mutant Kras-Driven Pancreatic Tumorigenesis in Mice. Proceedings of the National Academy of Sciences of the United States of America, 14, E4020-E4029. https://doi.org/10.1073/pnas.1616060114
|
[64]
|
Samanta, S., Yang, S., Debnath, B., et al. (2021) The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress—Mediated Apoptosis in Pancreatic Cancer. Cancer Research, 81, 1883-1895.
https://doi.org/10.1158/0008-5472.CAN-20-1540
|
[65]
|
Yuan, X.P., Dong, M., Li, X. and Zhou, J.P. (2015) GRP78 Promotes the Invasion of Pancreatic Cancer Cells by FAK and JNK. Molecular and Cellular Biochemistry, 398, 55-62. https://doi.org/10.1007/s11010-014-2204-2
|
[66]
|
Du, T., Li, H., Fan, Y., et al. (2019) The Deubiquitylase OTUD3 Stabilizes GRP78 and Promotes Lung Tumorigenesis. Nature Communications, 10, Article No. 2914. https://doi.org/10.1038/s41467-019-10824-7
|
[67]
|
Wu, J., Wu, Y. and Lian, X. (2020) Targeted Inhibition of GRP78 by HA15 Promotes Apoptosis of Lung Cancer Cells Accompanied by ER Stress and Autophagy. Biology Open, 9, Article ID: bio053298.
https://doi.org/10.1242/bio.053298
|
[68]
|
Zheng, Y., Liu, P., Wang, N., et al. (2019) Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 8781690. https://doi.org/10.1155/2019/8781690
|